Hematologic Malignancies: An Opportunity for Targeted Drug Therapy

Janice L. Gabrilove
The Oncologist 2001; 6(Supplement 5 ): 1-3; doi:10.1634/theoncologist.6-suppl_5-1
[Full Text] [PDF]  

Angiogenic Growth Factors: Autocrine and Paracrine Regulation of Survival in Hematologic Malignancies

Janice L. Gabrilove
The Oncologist 2001; 6(Supplement 5 ): 4-7; doi:10.1634/theoncologist.6-suppl_5-4
[Abstract] [Full Text] [PDF]  

Targeting Hypomethylation of DNA to Achieve Cellular Differentiation in Myelodysplastic Syndromes (MDS)

Lewis R. Silverman
The Oncologist 2001; 6(Supplement 5 ): 8-14; doi:10.1634/theoncologist.6-suppl_5-8
[Abstract] [Full Text] [PDF]  

Targeted Approaches for the Treatment of Thrombocytopenia

George D. Demetri
The Oncologist 2001; 6(Supplement 5 ): 15-23; doi:10.1634/theoncologist.6-suppl_5-15
[Abstract] [Full Text] [PDF]  

Vascular Endothelial Growth Factor Signaling Pathway as an Emerging Target in Hematologic Malignancies

Alan F. List
The Oncologist 2001; 6(Supplement 5 ): 24-31; doi:10.1634/theoncologist.6-suppl_5-24
[Abstract] [Full Text] [PDF]  

The Vascular Endothelial Growth Factor (VEGF) Signaling Pathway: A Therapeutic Target in Patients with Hematologic Malignancies

Francis J. Giles
The Oncologist 2001; 6(Supplement 5 ): 32-39; doi:10.1634/theoncologist.6-suppl_5-32
[Abstract] [Full Text] [PDF]  

To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.